The role of interleukin-6 gene in distinction of transudate-exudate in pleural effusions
Abstract
Purpose: This study aims to appraise IL-6 gene expression in pleural fluid samples and establish a connection between expression levels and promoter polymorphisms for more accurate pleural effusion classification.
Materials and Methods: A total of 38 adult patients (transudate (19) and exudate (19)) with pleural fluid and 33 healthy controls were included in the study. For the IL-6 gene expression study, RNA was isolated from transudate and exudate pleural fluids, and expression levels were compared between the two groups. Then, -174G>C (rs1800795), -572G>C (rs1800796) and, -597G>A (rs1800797) polymorphisms were analyzed using LightCycler® 480 II with real-time polymerase chain reaction from genomic DNA of controls and patients.
Results: IL-6 levels were 7.13-fold more expressed in the exudate group than in the transudate group. No significant difference was found between the transudate-exudate groups in terms of polymorphisms. However, when we compared the transudate-exudate patient groups with the control groups, -174 G>C polymorphism and -597 G>A polymorphism were statistically significant.
Conclusion: Pleural effusion treatment initiates with fluid characterization. In challenging cases, the current parameters are inadequate. Our findings indicate that IL-6 is a robust biomarker, independently distinguishing exudative and transudative states, surpassing traditional criteria. IL-6 shows promise for precise pleural effusion characterization, offering insights into pathophysiology and enabling targeted therapeutic interventions.
Keywords
IL-6 , mRNA Expression , Pleural Effusion , Genetic Polymorphism
Kaynakça
- Zielinska-Krawczyk M, Krenke R, Grabczak EM, Light RW. Pleural manometry–historical background, rationale for use and methods of measurement. Respir Med. 2018;136:21-8.
- Miserocchi G, Venturoli D, Negrini D, Del Fabbro M. Model of pleural fluid turnover. J Appl Physiol. 1993;75:1798-1806.
- Porcel JM, Light RW. Pleural effusions. Dis Mon. 2013;59:29-57.
- Maldonado F, Lentz RJ, Light RW. Diagnostic approach to pleural diseases: new tricks for an old trade. F1000Res. 2017;6:1135.
- Krishna R, Rudrappa M. Pleural Effusion. Treasure Island, FL; StatPearls Publishing; 2018.
- Feller-Kopman D, Light R. Pleural Disease N Engl J Med. 2018;378:740-51.
- Rosse C, Gaddum-Rosse P. Hollinshead’s Textbook of Anatomy. Baltimore, Lippincott Williams & Wilkins.; 1997.
- Tse HTK, Gossett DR, Moon YS, et al. Quantitative Diagnosis of Malignant Pleural Effusions by Single-Cell Mechanophenotyping. Sci Transl Med. 2013;5:212ra163.
- HEFFNER JE. Diagnosis and management of malignant pleural effusions. Respirology. 2007;13:5-20.
- Bouros D, Pneumatikos I, Tzouvelekis A. Pleural ınvolvement in systemic autoimmune disorders. Respiration. 2008;75:361-71.
